Skip to content
In-Office Drug Testing for Retinal Conditions episode artwork

Jan 6, 2010 13 min

In-Office Drug Testing for Retinal Conditions

from Revealing Retina

Host: Roy Levit, MD Guest: Allen Verne, MD What are the advantages to using private practices, as opposed to academic institutions, for testing medications? Dr. Allen Verne, president of the American Retina Foundation and founder of the Bay Area Retina Associates, discusses in-office drug studies he is involved in, including one on diabetic retinopathy and another on photodynamic therapy, and why these studies can be particularly useful in determining the most effective treatments for patients with retinal conditions. Dr. Verne also discusses the process of separating the interests of the pharmaceutical companies sponsoring studies and those participating in the study. What are the financial and time costs to the practices involved in in-office medication studies? Dr. Roy Levit hosts.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

In-Office Drug Testing for Retinal Conditions

0:00 13:00

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Revealing Retina?

This episode is 13 minutes long.

When was this Revealing Retina episode published?

This episode was published on January 6, 2010.

Can I download this Revealing Retina episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.